Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.

Ipca Laboratories Limited

Ipca Laboratories is involved in the development and manufacture of active pharmaceutical ingredients and formulations, catering to healthcare needs.

Metric
Company Name	Ipca Laboratories Limited
Symbol	IPCALAB
MSH ID	COM:IPCA
Market	STOCKS
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Country	IN
Stage
Employee Count	16.17K
Website	ipca.com
LinkedIn
Founders

Metric
Market Cap	3.67B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	909.67M
Revenue (LTM)
Revenue (NTM)
Gross Profit	361.69M
EBITDA	141.15M
Operating Income	98.97M
Net Income	64.62M
EPS	0.25
Diluted EPS	0.25
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.65
Operating Profit Margin	0.13
EBITDA Margin	0.16
Net Profit Margin	0.08
Return on Equity	0.13
Return on Assets	0.05
Return on Capital Employed	0.10

NSE:IPCALAB

Ipca Laboratories

Last Close

1,591.35

25/11 09:40

Market Cap

310.50B

Beta: 0.15

Volume Today

587.38K

Avg: 675.74K

PE Ratio

58.44

PFCF: -

Dividend Yield

0.18%

Payout:0%

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	58.44
P/B Ratio	4.68
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	5.20
EV Multiple	32.76

Metric
Days Sales Outstanding	96.63
Days Payables Outstanding	123.70
Days Inventory Outstanding	287.28
Operating Cycle	367.59
Cash Conversion Cycle	277.38
Asset Turnover	0.74

Metric
Operating Cash Flow	105.52M
Free Cash Flow	56.96M
Cash Flow to Debt	0.47
Operating Cash Flow/Sales	0.09
Free Cash Flow Yield

Metric
Cash & Equivalents	35.05M
Accounts Receivable	-8.95M
Inventory	291.77M
Goodwill	10.69M
Debt to Capitalization	0.18
Debt to Assets	0.17
Current Ratio	2.13
Quick Ratio	1.30

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue